Dasatinib-Induced Colitis in a Patient with Chronic Myelogenous Leukemia
Saved in:
Main Authors: | Perdigoto,David N., Lopes,Sandra, Portela,Francisco, Cipriano,Maria Augusta, Tomé,Luís |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Portuguesa de Gastrenterologia
2018
|
Online Access: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452018000400008 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic myelogenous leukemia: the present and the future of the TKI therapy
by: Saglio,Giuseppe, et al.
Published: (2009) -
The genetic basis of chronic myelogenous and acute lymphoblastic leukemia
by: Stam, K. -
Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase?
by: Almeida Filho,T.P. de, et al.
Published: (2019) -
Dasatinib: clinical trials and management of adverse events in imatinib resistant/intolerant chronic myeloid leukemia
by: Conchon,Monika, et al.
Published: (2011) -
Molecular basis of Acute Myelogenous Leukemia
by: Rego,Eduardo M.
Published: (2002)